Rare diseases
Investigational molecules
Locations
275 Shoreline Drive Suite 500, 94065-1413, United States
Rezolute Inc. focuses on clinical research in hypoglycemia associated with congenital hyperinsulinism, with attention to stabilizing blood glucose in patients affected by excessive insulin secretion. Its studies address the management of recurrent low blood sugar and the need for improved glycemic control.
The research activity in this area is centered on improving day-to-day metabolic stability for individuals living with this rare endocrine disorder.
Rezolute Inc. runs clinical trials in conditions such as Hyperinsulinaemic hypoglycaemia, Hyperinsulinism, Insulinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
